- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ONC Touts Progress on Integrating Patient-Generated Data
The Health IT Policy Committee (HITPC) adopted recommendations from its Consumer Empowerment Workgroup on patient-generated health data (PGHD) at its December meeting and is expected to finalize its complete Stage 3 recommendations in February.
The Health IT Policy Committee (HITPC) adopted recommendations from its Consumer Empowerment Workgroup on patient-generated health data (PGHD) at its December meeting and is expected to finalize its complete Stage 3 recommendations in February.
The committee reaffirmed that its objective--"patients [should] have the ability to electronically submit patient-generated health information"--should be part of Meaningful Use Stage 3, according to a report from a technical expert panel convened at the request of the Office of the National Coordinator.
This data, which could be submitted by a patient, caregiver or other designee, "could be an observation, a test result, a device finding, a confirmation or a change/correction/addition of data in the patient's existing health record"--data collected outside the clinical visit, explains a blog post at HealthITBuzz.
"As 2013 draws to a close, we are pleased to report that a lot of progress has made," writes Mary Jo Deering, senior policy advisor in the Office of Policy and Planning, of the ONC's efforts to better understand and implement policies concerning this data.
Read the full story here: http://bit.ly/19FezPe
Source: Fierce Health IT
Niraparib Extends PFS, Time to Next Treatment in Patients With EOC, Especially BRCA-Mutated Cases
January 28th 2025First-line maintenance (1LM) niraparib significantly extends progression-free survival (rwPFS) and time to next treatment (rwTTNT) in patients with epithelial ovarian cancer (EOC), with the greatest benefit observed in those considered homologous recombination-deficient (HRd) and those with BRCA-mutated (BRCAm) tumors.
Read More
